FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Device, Hemostasis, Vascular

PMA: P050007 · Supplement: S048 · Decision Mar 2, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P050007 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Device, Hemostasis, Vascular
Trade Name
StarClose SE™ Vascular Closure System
PMA Number
P050007
Supplement Number
S048
Device Class
FDA Class 3
Product Code
MGB
Generic Name
Device, hemostasis, vascular
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
March 2, 2026
Date Received
February 2, 2026
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

a modification to the sustainable ethylene oxide (SEO) cycle previously approved for Line 1, Line 2, Line 14 and Line 15 at Synergy Health Ireland and implementation of the SEO cycle at Sterigenics Los Angeles

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MGB Device, Hemostasis, Vascular